YUE LIN

Dr. YUE LIN


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
XXXinsheng Xie
Xinsheng Xie
XHXiang Hong
Xiang Hong
CHChai shi Hong
Chai shi Hong
YHYulong Huang
Yulong Huang
GCGang Chen Chen
Gang Chen Chen
LWLixin Wang
Lixin Wang
Background: The molecular mechanisms associated with thoracic aortic dissection (TAD) remain poorly understood. A comprehensive high-throughput sequencing-based analysis of the circRNA–miRNA–mRNA competitive endogenous RNA (ceRNA) regulatory network in TAD has not been conducted. The purpose of this study is to identify and verify the key ceRNA networks which may have crucial biological functions in the pathogenesis of TAD. Methods: Gene expression profiles of the GSE97745, GSE98770, and GSE52093 datasets were acquired from the Gene Expression Omnibus (GEO) database. Differentially expressed genes (DEGs) were identified using the GEO2R tools. Protein–protein interaction (PPI) networks of the hub genes were constructed using STRING; the hub genes and modules were identified by MCODE and CytoHubba plugins of the Cytoscape. We analyzed the hub genes using Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis. The functions of these hub genes were assessed using Cytoscape software. Our data—along with data from GSE97745, GSE98770, and GSE52093—were used to verify the findings. Results: Upon combined biological prediction, a total of 11 ce-circRNAs, 11 ce-miRNAs, and 26 ce-mRNAs were screened to construct a circRNA–miRNA–mRNA ceRNA network. PPI network and module analysis identified four hub nodes, including IGF1R, JAK2, CSF1, and GAB1. Genes associated with the Ras and PI3K-Akt signaling pathways were clustered in the four hub node modules in TAD. The node degrees were most significant for IGF1R, which were also the most significant in the two modules (up module and hub module). IGF1R was selected as a key gene, and the hsa_circ_0007386/miR-1271–5P/IGF1R/AKT regulatory axis was established. The relative expression levels of the regulatory axis members were confirmed by RT-PCR in 12 samples, including TAD tissues and normal tissues. Downregulation of IGF1R expression in smooth muscle cells (SMCs) was found to induce apoptosis by regulating the AKT levels. In addition, IGF1R showed high diagnostic efficacy in both AD tissue and blood samples. Conclusions: The hsa_circ_0007386/miR-1271-5P/IGF1R/AKT axis may aggravate the progression of TAD by inducing VSMCs apoptosis. CeRNA networks could provide new insights into the underlying molecular mechanisms of TAD. In addition, IGF1R showed high diagnostic efficacy in both tissue and plasma samples in TAD, which can be considered as a diagnostic marker for TAD.

5 June 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
YLYUE LIN
YUE LIN
FLFanzhen Lv
Fanzhen Lv
YHYulong Huang
Yulong Huang
GCGang Chen Chen
Gang Chen Chen
CHChai shi Hong
Chai shi Hong
WFWeiguo Fu
Weiguo Fu
Objectives: The objective of this study was to evaluate the real-world efficacy of minimally invasive revascularization in diabetic foot ischemia, focusing on novel insights into device selection and lesion-specific predictors. Methods: This retrospective study included 98 patients (101 limbs) undergoing endovascular/hybrid interventions. The primary endpoints were 1- and 2-year primary patency and freedom from clinically driven target lesion revascularization (CD-TLR). Multivariate Cox regression identified restenosis predictors, with subgroup analysis comparing drug-coated devices (DCDs) versus conventional strategies in chronic limb-threatening ischemia (CLTI). Results: The cohort (mean age 72.1 ± 8.9 years) comprised 51% CLTI limbs (28.5% with tissue loss). The overall 1-year primary patency was 75.6%, declining to 67.6% after 2 years. The rates of freedom from CD-TLR were 87.4% after 1 year and 74.8% after 2 years. CLTI was associated with significantly reduced 1-year (66.5% vs. 84.9%) and 2-year primary patency (56.3% vs. 80.1%; log-rank p = 0.026) compared to non-CLTI. Multivariate analysis identified CLTI as an independent predictor of restenosis (HR 3.375, 95%CI 1.267–8.990, p = 0.015). Although DCDs did not improve 2-year primary patency in CLTI (58.5% vs. 57.3%, p = 0.768), they demonstrated superior 2-year CD-TLR-free survival (78.5% vs. 54.6%, p = 0.048). The total complication rate was 5.9%, with no significant difference between CLTI and non-CLTI groups (11.5% vs. 0%, p = 0.057). Conclusions: This study highlights CLTI’s impact on revascularization durability and the clinical benefits of DCDs in reducing reinterventions, offering evidence-based insights for tailored device selection despite retrospective limitations.

1 April 2025 in Science Progress
Verified
Journal Article
Open access
YLYUE LIN
YUE LIN
TPTianyue Pan
Tianyue Pan
SHShichai Hong
Shichai Hong
WLWeifeng Lu
Weifeng Lu
WFWeiguo Fu
Weiguo Fu
XXXinsheng Xie
Xinsheng Xie
Objective: The aim of this study was to evaluate the efficacy of hybrid therapy and endovascular therapy in the treatment of complex femoropopliteal Trans-Atlantic Inter-Society Consensus II D(TASC D) lesions involving the common femoral artery bifurcation. Methods: Patients with complex femoropopliteal TASC D lesions involving the bifurcation of the common femoral artery for atherosclerotic disease were retrospectively analyzed in our institution from July 2018 to July 2023. Patients were followed up at 1, 3, 6, and 12 months and then every year. Clinical data were collected, including perioperative and follow-up information. The patency rate and the rate of freedom from clinically driven target lesion revascularization (CD-TLR) were measured using the Kaplan–Meier method. Results: A total of 29 patients with 31 limbs (mean age 73.5 ± 11.5 years; 20 men) were included, divided into the hybrid therapy group (20 limbs, Group 1) and endovascular treatment group (11 limbs, Group 2). The mean follow-up time was 22.5 ± 16.3 months (1–60 months), and the mean length of the lesion was 31.5 ± 11.6 cm. Between these two groups, there was no statistically significant difference on baseline data P >.05). Group 1 had more long-segment chronic total occlusive (CTO) lesions than Group 2( P <.05). Totally, the 1- and 2-year patency rates of TASC D lesions were 74.6% and 55.2%, respectively; and the rate of freedom from CD-TLR was 81.2% and 70.3%, respectively. There was no statistically significant difference between these two groups in terms of 1-year primary patency rate(88.7% vs 100%) and freedom from CD-TLR of the common femoral artery (CFA) bifurcation(93.8% vs 100%)( P >.05). Conclusions: For common femoral artery bifurcation lesions, both hybrid endarterectomy and endovascular treatment demonstrate favorable clinical outcomes. While these findings support their use, definitive conclusions on comparative efficacy remain conditional on confirmation from large-scale, long-term studies.

6 March 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
GCGang Chen Chen
Gang Chen Chen
YLYUE LIN
YUE LIN
YPYa Peng
Ya Peng
CHChai shi Hong
Chai shi Hong
XHXiang Hong
Xiang Hong
WLWeifeng Lu
Weifeng Lu
Background/Objectives: Rates of postoperative recurrence of varicose veins range from 7% to 62%. We analyzed factors associated with recurrent varicose veins (RVVs) of the lower extremities after interventional treatment. Methods: We enrolled 99 patients (114 lower extremities) with RVVs admitted from January 2018 to June 2025 (71 women, 76 limbs; 28 men, 31 limbs; average age (SD) 63.9 (9.8) years). Duplex ultrasound scanning, magnetic resonance venography, or computed tomography venography were performed. The presence of a residual great saphenous vein, primary deep venous valve insufficiency, incompetent perforating veins, and iliac vein stenosis were recorded. We analyzed the charts of patients who underwent operations for recurrent varicose veins for associated factors. Results: We recorded residual trunk of the great saphenous vein in 55 limbs (48.3%), deep venous valve insufficiency in 47 (41.2%), incompetent perforating veins in 7 (6.1%), anterior accessory saphenous vein insufficiency in 2 (1.8%), and small saphenous vein insufficiency in 2 (1.8%). Iliofemoral venography indicated 31 limbs (27.2%; left lower, 24; right lower, 7) with a nonthrombotic iliac vein compression lesion. After identifying associated factors, retreatments—high ligation and stripping of the great saphenous vein or iliac vein stent implantation or small saphenous vein dissection ligation and stripping—were performed. The venous clinical severity score was 7 (interquartile range, 5–10) on admission and 3 (interquartile range, 2–4) 3 months after discharge.Conclusions: RVVs are associated with multiple factors, including inadequate initial surgical techniques, nonthrombotic iliac vein compression lesions, deep venous valve insufficiency, small saphenous vein insufficiency, and incompetent perforating veins. Performing detailed imaging before retreatment is essential to identify factors associated with RVVs and prevent recurrence.

28 October 2026 in Journal of Vascular Diseases
Verified
Journal Article
Open access
PDF file
GCGang Chen Chen
Gang Chen Chen
YLYUE LIN
YUE LIN
TYTong Yuan
Tong Yuan
YPYa Peng
Ya Peng
XXXinsheng Xie
Xinsheng Xie
WLWeifeng Lu
Weifeng Lu
Background: The reported postoperative recurrence rates of lower limb varicose veins differ considerably across studies, ranging from 7% to 62%. This study aimed to characterize the clinical and imaging findings in patients presenting with recurrent varicose veins (RVVs) and to describe short-term clinical outcomes after individualized reintervention. Methods: We enrolled 99 patients (114 lower extremities) with RVVs admitted from January 2018 to June 2025. All patients underwent duplex ultrasound scanning; computed tomography venography or magnetic resonance venography was performed to assess iliac vein anatomy. We analyzed the charts of patients for the prevalence of imaging and clinical abnormalities among patients with RVVs. This study was designed as a descriptive retrospective case series without a non-recurrent control group. We analyzed the distribution of venous abnormalities among the included limbs. Results: The mean patient age was 63.9 ± 9.8 years, and 71.7% of the patients were female. Among the 114 affected limbs, residual great saphenous vein trunks were identified in 55 (48.3%), deep venous reflux in 47 (41.2%), incompetent perforating veins in 7 (6.1%), anterior accessory great saphenous vein reflux in 2 (1.8%), and small saphenous vein reflux in 2 (1.8%). Iliac vein stenosis was suspected in 42 limbs, of which 38 underwent digital subtraction angiography; nonthrombotic iliac vein compression lesions were confirmed in 31 limbs. Confirmed lesions were more frequent in left-sided than right-sided RVVs limbs (35.8% vs. 16.3%; p = 0.03). The median venous clinical severity score decreased from 7 (interquartile range, 5–10) at admission to 2 (interquartile range, 2–3) 6 months after discharge (p < 0.01). All 20 active venous ulcers healed during follow-up. Conclusions: Residual great saphenous vein trunks, deep venous valve insufficiency, and nonthrombotic iliac vein compression lesions were frequently observed venous abnormalities in this retrospective descriptive case series of patients with RVVs. Comprehensive multimodal venous imaging may assist individualized reintervention planning. These findings describe a referred recurrent case series and cannot be interpreted as risk factors for recurrence without a non-recurrent control group. Long-term outcomes require further investigation.

25 October 2025 in Journal of Mechanics in Medicine and Biology
Verified
Journal Article
Closed access
YZYuyao Zhang
Yuyao Zhang
SHShichai Hong
Shichai Hong
YLYUE LIN
YUE LIN